White paper
The next generation of antibody research: Insights from the leading biopharmas in the Nordics
AI is already transforming antibody discovery, and biopharma innovators in the Nordics are at the forefront. At Benchling’s Nordics Digital Day, leaders in biologics R&D from Ferring, Lundbeck, Novo Nordisk, and Symphogen sat down to explore how AI is being used today, where it’s falling short, and what’s needed to unlock its full potential. The question at hand: How ready is the field for the next wave of innovation in antibody discovery?
In this white paper, you’ll discover:
How scientists are using AI to better predict candidate properties earlier in the pipeline
Why “Frankenstein” formats pose unique hurdles for current AI models
The strategies biopharmas are using to develop structured, model-ready data
View white paper
Join over 200,000 scientists using Benchling to power their biotech R&D
